Utilization of silkworm as a biocommodities, pathological model,
or
evaluation methods for small molecule compound and therapeutic technology development
or
evaluation methods for small molecule compound and therapeutic technology development
Biocommodities
○ Biopharmacy
(1)Proteins / antibodies
(2)Nucleic acids
1)Nucleic acid for medical
2)Encapsulation carrier
○ Shade type virus
○ Biopharmacy
(1)Proteins / antibodies
(2)Nucleic acids
1)Nucleic acid for medical
2)Encapsulation carrier
○ Shade type virus
Basic technology
○Gene transfer
○Genome editing
○Electroporation
○Gene transfer
○Genome editing
○Electroporation
Evaluation model
○Pathological model candidates
• Neurological disease model
(Ischemic brain disease, Alzheimer's disease Parkinson's disease, etc.)
• Infectious disease model
(Search and evaluation of antibiotics, microorganisms, etc.)
• Diabets model
• Cardiovascular disease model
(Ischemic heart / kidney disease, hypertension, etc.)
• Autoimmune disease
(Periodontal disease, etc.)
• Pain
○Treatment technology development
• Drug delivery system
○Visualization of intramolecular interactions
○Pathological model candidates
• Neurological disease model
(Ischemic brain disease, Alzheimer's disease Parkinson's disease, etc.)
• Infectious disease model
(Search and evaluation of antibiotics, microorganisms, etc.)
• Diabets model
• Cardiovascular disease model
(Ischemic heart / kidney disease, hypertension, etc.)
• Autoimmune disease
(Periodontal disease, etc.)
• Pain
○Treatment technology development
• Drug delivery system
○Visualization of intramolecular interactions
We plan to release new finding information and results that can be.